1st Quarter - Report — PREMIER, INC. for PREMIER, INC. (2009)

Firm

PREMIER, INC.

Client

PREMIER, INC.

Income

—

Expenses

$160,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Physicians Payments Sunshine Act Healthcare Group Purchasing Value-Based Medicare Purchasing Healthcare Associated Infections Health Information Technology IVIG Average Sales Price for Medicare Part B Drugs Medicare, Medicaid and CHIP Unique Device Identification H.R.7067 - Quality First Act Physician Self-Referral Medicaid Outpatient Graduate Medical Education Medicaid 340B Program H.R. 1 - American Recovery and Reinvestment Act of 2009 H.R. 2 - Children's Health Insurance Program Comparative Effectiveness

Lobbyist	Covered position, as disclosed
BLAIR GORDON CHILDS	—
MARGARET REAGAN	—
LINDA ROUSE O'NEILL	—
SARAH WACHTEL	—
JOHN DAVID WHITE	—

Contacted: Internal Revenue Service (IRS); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Government Accountability Office (GAO); SENATE; Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2 (111th), H.R. 1 (111th), H.R. 7067 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.